Received Apr 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
Patient never received 2nd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 20-year-old male patient who did not receive Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (received first dose on 15-DEC-2022). The patient did not receive the 2nd dose of Bexsero. The patient experienced incomplete course of vaccination (Verbatim: Patient never received 2nd dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:30-MAR-2026 The reporter needs to know if the patient needs to restart the series or just to receive a booster.